Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has a beta of 0.17, a 12-month trailing P/E ratio of 14.81, and a growth ratio of 3.70. The stock’s Relative
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) previous close was $514.99 while the outstanding shares total 105.40M. The firm has a beta of 0.18, a 12-month trailing P/E
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) shares fell to a low of $501.20 before closing at $505.36. Intraday shares traded counted 0.68 million, which was 19.53% higher
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) shares fell to a low of $493.1866 before closing at $498.03. Intraday shares traded counted 0.76 million, which was 11.4% higher
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
